Haleon PLC (HLN)
9.775
+0.02
(+0.15%)
USD |
NYSE |
Nov 05, 16:00
9.775
0.00 (0.00%)
After-Hours: 19:49
Haleon Market Cap: 44.20B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 44.13B |
| November 01, 2024 | 43.99B |
| October 31, 2024 | 43.81B |
| October 30, 2024 | 44.31B |
| October 29, 2024 | 44.76B |
| October 28, 2024 | 45.12B |
| October 25, 2024 | 44.54B |
| October 24, 2024 | 44.72B |
| October 23, 2024 | 44.76B |
| October 22, 2024 | 44.81B |
| October 21, 2024 | 45.12B |
| October 18, 2024 | 45.62B |
| October 17, 2024 | 45.58B |
| October 16, 2024 | 45.80B |
| October 15, 2024 | 45.31B |
| October 14, 2024 | 45.67B |
| October 11, 2024 | 45.44B |
| October 10, 2024 | 45.76B |
| October 09, 2024 | 45.53B |
| October 08, 2024 | 45.85B |
| October 07, 2024 | 45.35B |
| October 04, 2024 | 46.89B |
| October 03, 2024 | 47.02B |
| October 02, 2024 | 48.08B |
| October 01, 2024 | 48.77B |
| Date | Value |
|---|---|
| September 30, 2024 | 48.26B |
| September 27, 2024 | 48.57B |
| September 26, 2024 | 48.20B |
| September 25, 2024 | 48.21B |
| September 24, 2024 | 48.53B |
| September 23, 2024 | 48.39B |
| September 20, 2024 | 47.89B |
| September 19, 2024 | 47.62B |
| September 18, 2024 | 48.04B |
| September 17, 2024 | 48.50B |
| September 16, 2024 | 48.36B |
| September 13, 2024 | 47.87B |
| September 12, 2024 | 47.28B |
| September 11, 2024 | 47.51B |
| September 10, 2024 | 47.83B |
| September 09, 2024 | 47.33B |
| September 06, 2024 | 47.06B |
| September 05, 2024 | 47.02B |
| September 04, 2024 | 46.88B |
| September 03, 2024 | 46.29B |
| August 30, 2024 | 46.39B |
| August 29, 2024 | 45.98B |
| August 28, 2024 | 45.52B |
| August 27, 2024 | 45.44B |
| August 26, 2024 | 44.98B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
26.00B
Minimum
Sep 02 2022
48.77B
Maximum
Oct 01 2024
37.68B
Average
38.00B
Median
Mar 20 2024
Market Cap Benchmarks
| Pfizer Inc | 158.55B |
| GSK PLC | 75.52B |
| Smith & Nephew PLC | 11.16B |
| Adaptimmune Therapeutics PLC | 212.01M |
| Biodexa Pharmaceuticals PLC | 3.281M |
Market Cap Related Metrics
| PE Ratio | 28.89 |
| PS Ratio | 3.152 |
| PEG Ratio | 17.24 |
| Price to Book Value | 2.105 |
| Price | 9.775 |
| Earnings Yield | 3.46% |
| PEGY Ratio | 8.775 |
| Operating PE Ratio | 16.58 |
| Normalized PE Ratio | 29.00 |